Bajgain, Pradip
Tawinwung, Supannikar
D’Elia, Lindsey
Sukumaran, Sujita
Watanabe, Norihiro
Hoyos, Valentina
Lulla, Premal
Brenner, Malcolm K.
Leen, Ann M.
Vera, Juan F.
Funding for this research was provided by:
National Cancer Institute (P01 CA094237, P50 CA126752, P50 CA186784, P30 CA125123)
Pancreatic Cancer Action Network (16-65-LEEN)
American Cancer Society (MRSG-14-197-01–LIB)
Cancer Prevention and Research Institute of Texas (RR170024)
V Foundation for Cancer Research (T2016-006)
Elsa U. Pardee Foundation
Adrienne Helis Malvin Medical Research Foundation
Article History
Received: 22 January 2018
Accepted: 26 April 2018
First Online: 10 May 2018
Ethics approval and consent to participate
: Collection of human peripheral blood mononuclear cells (PBMCs) were obtained from healthy donors and patients after informed consent on protocols approved by the Institutional Review Board (IRB) at Baylor College of Medicine (H-15152). Mice were housed and treated in accordance with Baylor College of Medicine Animal Husbandry and Institutional Animal Care and Use Committee guidelines (AN-5639).
: The Center for Cell and Gene Therapy at Baylor College of Medicine established a collaboration with Celgene at the time the work was conducted. S.S., A.M.L., and J.F.V. have filed a related patent application.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.